CVRdatabase
Menu

HHC Medical ApS

Private limited companyCVR 40723420København NActive

HHC Medical ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2019. Equity was negative at the end of 2025 (−DKK 18.2m). The company made a loss in both 2024 and 2025, most recently DKK 6.1m. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 1.3m+62.9% vs. 2024
Net profit−DKK 6.1m+21.2% vs. 2024
Equity−DKK 18.2m−50.6% vs. 2024
Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 7.8m to DKK 6.1m (2024 → 2025).

Employees

  • 5 fewer employees than a year earlier: 6 (07/2026) against 11 (07/2025).

Management and owners, last 24 months

  • New in management: Thomas Hattel Smith (director, 12/12/2025) and Alexander Korre Viterbo-Horten (director, 12/12/2025).
  • Stepped down: Alexander Korre Viterbo-Horten (director, 24/06/2026).
  • New owners registered: CFH-Holding ApS (05/12/2025) and Smith Tech Holding ApS (05/12/2025).
  • No longer registered as owner: CFH-Holding ApS (04/12/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 18m−DKK 16m−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
EquityNet profit
Financial figures for HHC Medical ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−70726−441−1,594−3,527−1,307+62.9%
Operating profit (EBIT)−70382−1,374−4,073−8,443−6,553+22.4%
Profit before tax−71380−1,412−4,337−9,459−7,868+16.8%
Net profit−71342−1,131−3,507−7,761−6,117+21.2%
Total assets393904,52610,9026,9666,152−11.7%
Equity−31311−820−4,327−12,088−18,204−50.6%
Liabilities70795,34515,22919,05324,356+27.8%
Cash and cash equivalents252783,6979,0224,9043,705−24.4%
Average number of employees012478+14.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 18.2m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for HHC Medical ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202525/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202404/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202315/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202202/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202124/06/2022The companyPDFXBRL
202019/08/2019 – 31/12/202006/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 1.3mNo. 334 of 421
Better than 21% of the companies in the industry
Equity−DKK 18.2mNo. 413 of 431
Better than 4% of the companies in the industry
Number of employees6No. 158 of 431
Better than 63% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,935of 69,742
Better than 1%
No. 69,761of 69,964
Better than 0%
Same industry and fewer than 20 employees329 companies in the comparison
No. 255of 323
Better than 21%
No. 320of 329
Better than 3%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,207of 33,588
Better than 1%
No. 33,497of 33,687
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 65,745of 66,379
Better than 1%
No. 66,305of 66,505
Better than 0%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. HHC Medical ApS−DKK 1.3m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. HHC Medical ApS−DKK 6.1m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. HHC Medical ApS−DKK 18.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. HHC Medical ApS6
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Viterbo-Horten Holding ApS10%
  • Jerichau Holding ApS33.33%
  • CFH-Holding ApS25%
  • Smith Tech Holding ApS25%
HHC Medical ApS

Management

3 active registrations

Executive management

Executive management at HHC Medical ApS
NameRoleAppointed
Niels Christian Jerichau ClausenCEO26/07/2023
Carl Frederik Halskou HaugaardDirector26/07/2023
Thomas Hattel SmithDirector12/12/2025
Founders
Jerichau Holding ApS, Viterbo-Horten Holding ApS, CFH-Holding ApS
Former management (2)
Former management at HHC Medical ApS
NameRoleAppointedResigned
Niels Christian Jerichau ClausenDirector19/08/201925/07/2023
Alexander Korre Viterbo-HortenDirector12/12/202524/06/2026

Signing rule: Selskabet tegnes af to direktører i forening.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
HHC Medical ApSOle Maaløes Vej 3, 2200 København N61024954761

Purpose

The purpose of the company is to engage in medical and biotech research, development, production, sales, services, and related activities.

The purpose is quoted from the register in Danish.

Changes year by year

24 registered events
20262 changesaccounts 1 · management 1
  • Annual report for 2025 published
  • Alexander Korre Viterbo-Horten stepped down as director
20257 changesmanagement 2 · ownership 3 · accounts 1 · industry 1
  • Alexander Korre Viterbo-Horten appointed director
  • Thomas Hattel Smith appointed director
  • CFH-Holding ApS registered as owner (25%)
  • Smith Tech Holding ApS registered as owner (25%)
  • CFH-Holding ApS is no longer registered as owner
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
  • Annual report for 2023 published
20237 changesownership 2 · address 1 · management 3 · accounts 1
  • Jerichau Holding ApS registered as owner (33.33%)
  • Jerichau Holding ApS is no longer registered as owner
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Niels Christian Jerichau Clausen appointed ceo
  • Carl Frederik Halskou Haugaard appointed director
  • Niels Christian Jerichau Clausen stepped down as director
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20195 changesfounded 1 · management 1 · ownership 3
  • Registered as HHC Medical ApS
  • Niels Christian Jerichau Clausen appointed director
  • Jerichau Holding ApS registered as owner (50%)
  • CFH-Holding ApS registered as owner (33.33%)
  • Viterbo-Horten Holding ApS registered as owner (10%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction